| Year |
Citation |
Score |
| 2020 |
Goldkorn A, Tangen C, Plets M, Morrison G, Cunha A, Xu T, Pinski JK, Ingles SA, Triche T, MacVicar GR, Vaena DA, Crispino AW, McConkey DJ, Lara P, Hussain MHA, et al. Baseline circulating tumor cell (CTC) count as a prognostic marker of PSA response and progression in metastatic castrate sensitive prostate cancer (mCSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide. Journal of Clinical Oncology. 38: 5506-5506. DOI: 10.1200/Jco.2020.38.15_Suppl.5506 |
0.322 |
|
| 2020 |
Morrison GJ, Buckley J, Ostrow DG, Varghese B, Ericson N, Cen S, Cunha A, Lu Y, George T, Smith J, Quinn D, Duddalwar V, Triche T, Goldkorn A. Abstract 5379: Non-invasive profiling of advanced prostate cancer via multi-parametric liquid biopsy and radiomics Clinical Trials. 80: 5379-5379. DOI: 10.1158/1538-7445.Am2020-5379 |
0.346 |
|
| 2020 |
Kang H, Nagy J, Triche T. Abstract 1717: Targeted NanoSpheres (TNS): An effective, non-toxic nano-formulated therapeutic platform for broad use in cancer treatment Cancer Research. 80: 1717-1717. DOI: 10.1158/1538-7445.Am2020-1717 |
0.36 |
|
| 2019 |
George JW, Fan H, Johnson B, Carpenter TJ, Foy KK, Chatterjee A, Patterson AL, Koeman J, Adams M, Madaj ZB, Chesla D, Marsh EE, Triche TJ, Shen H, Teixeira JM. Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids. Cell Reports. 29: 4069-4085.e6. PMID 31851934 DOI: 10.1016/J.Celrep.2019.11.077 |
0.358 |
|
| 2019 |
Tew BY, Legendre C, Schroeder MA, Triche T, Gooden GC, Huang Y, Butry L, Ma DJ, Johnson K, Martinez RA, Pierobon M, Petricoin EF, O'Shaughnessy J, Osborne C, Tapia C, et al. Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones. Neuro-Oncology. PMID 31433055 DOI: 10.1093/Neuonc/Noz137 |
0.322 |
|
| 2019 |
Negri GL, Grande BM, Delaidelli A, El-Naggar A, Cochrane D, Lau CC, Triche TJ, Moore RA, Jones SJM, Montpetit A, Marra MA, Malkin D, Morin RD, Sorensen PH. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma. The Journal of Pathology. PMID 31236944 DOI: 10.1002/Path.5319 |
0.382 |
|
| 2019 |
Triska P, Kaneva K, Merkurjev D, Sohail N, Falk MJ, Triche TJ, Biegel JA, Gai X. Landscape of germline and somatic mitochondrial DNA mutations in pediatric malignancies. Cancer Research. PMID 30709931 DOI: 10.1158/0008-5472.Can-18-2220 |
0.302 |
|
| 2019 |
Wang J, Van Den Berg D, Hwang AE, Weisenberger D, Triche T, Nathwani BN, Conti DV, Siegmund K, Mack TM, Horvath S, Cozen W. DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin. Leukemia & Lymphoma. 1-9. PMID 30668190 DOI: 10.1080/10428194.2018.1533128 |
0.532 |
|
| 2019 |
Underwood JG, Smith JL, Call LF, Tseng E, Hylkema TA, Ries RE, Leonti AR, Farrar JE, Triche TJ, Meshinchi S. Discovery of Novel IL3RA (CD123) Isoforms By Long Read Transcriptomics, Heterogeneous Expression Among AML Patient Cohorts and the Implications for Anti-CD123 Therapeutics Blood. 134: 4658-4658. DOI: 10.1182/Blood-2019-131508 |
0.355 |
|
| 2019 |
Smith JL, Ries RE, Farrar JE, Alonzo TA, Gerbing RB, Leonti AR, Hylkema TA, Gamis AS, Aplenc R, Kolb EA, Nguyen C, Meerzaman D, Triche TJ, Meshinchi S. Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia - a COG and Tpaml Study Blood. 134: 2741-2741. DOI: 10.1182/Blood-2019-127318 |
0.349 |
|
| 2019 |
Ries RE, Leonti AR, Triche TJ, Gerbing RB, Hirsch BA, Raimondi SC, Smith JL, Cooper TM, Farrar JE, Deshpande AJ, Kolb EA, Gamis AS, Aplenc R, Alonzo TA, Meshinchi S. Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene - a COG/Tpaml Study Blood. 134: 461-461. DOI: 10.1182/Blood-2019-125943 |
0.352 |
|
| 2019 |
Mitra SA, Ravinder N, Magnon V, Nagy J, Triche TJ. Abstract 4499: Genomic editing of EWS-FLI1 and its targets, and its therapeutic potential in treatment of Ewing sarcoma Cancer Research. 79: 4499-4499. DOI: 10.1158/1538-7445.Am2019-4499 |
0.386 |
|
| 2018 |
Lorentzian A, Biegel JA, Ostrow DG, Rolf N, Liu CC, Rassekh SR, Deyell RJ, Triche T, Schultz KR, Rozmus J, Reid GSD, Lim CJ, Lange PF, Maxwell CA. Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies. Jnci Cancer Spectrum. 2: pky079. PMID 30976750 DOI: 10.1093/Jncics/Pky079 |
0.373 |
|
| 2018 |
Capone S, Colombo AR, Johnson BK, Triche TJ, Ramsingh G. Methylome of human senescent hematopoietic progenitors Experimental Hematology & Oncology. 7: 1-7. PMID 30598855 DOI: 10.1186/S40164-018-0123-8 |
0.35 |
|
| 2018 |
McEachron TA, Triche TJ, Sorenson L, Parham DM, Carpten JD. Profiling targetable immune checkpoints in osteosarcoma. Oncoimmunology. 7: e1475873. PMID 30524885 DOI: 10.1080/2162402X.2018.1475873 |
0.406 |
|
| 2018 |
Colombo AR, Triche T, Ramsingh G. Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis. Scientific Reports. 8: 16449. PMID 30401833 DOI: 10.1038/S41598-018-34189-X |
0.376 |
|
| 2018 |
Xicola RM, Manojlovic Z, Augustus GJ, Kupfer SS, Emmadi R, Alagiozian-Angelova V, Triche T, Salhia B, Carpten J, Llor X, Ellis NA. Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans. Carcinogenesis. PMID 30239619 DOI: 10.1093/Carcin/Bgy122 |
0.302 |
|
| 2018 |
Hiemenz MC, Ostrow DG, Busse TM, Buckley J, Maglinte DT, Bootwalla M, Done J, Ji J, Raca G, Ryutov A, Xu X, Zhen CJ, Conroy JM, Hazard FK, Deignan JL, ... ... Triche TJ, et al. OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies. The Journal of Molecular Diagnostics : Jmd. PMID 30138724 DOI: 10.1016/J.Jmoldx.2018.06.009 |
0.394 |
|
| 2018 |
Xu L, Zheng Y, Liu J, Rakheja D, Singleterry S, Laetsch TW, Shern JF, Khan J, Triche TJ, Hawkins DS, Amatruda JF, Skapek SX. Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes. Cell Reports. 24: 238-251. PMID 29972784 DOI: 10.1016/J.Celrep.2018.06.006 |
0.367 |
|
| 2018 |
Capone S, Connor KM, Colombo A, Li X, Triche TJ, Ramsingh G. Senescent human hematopoietic progenitors show elevated expression of transposable elements and inflammatory genes. Experimental Hematology. PMID 29549053 DOI: 10.1016/J.Exphem.2018.03.003 |
0.36 |
|
| 2018 |
Triche TJ, Johnson BK, Heo L, Huang YP, Ries RE, Bolouri H, Farrar JE, Meshinchi S. Selective Pressure from Chemotherapy Drives Convergent Evolution in Relapsing and Refractory AML across Age Groups Blood. 132: 2609-2609. DOI: 10.1182/Blood-2018-99-119323 |
0.313 |
|
| 2018 |
Triche TJ, Nagy J, Kang H, Denny C, Mitra SB. Abstract A28: Targeted therapy of Ewing sarcoma Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-A28 |
0.355 |
|
| 2018 |
Tew BY, Legendre C, Triche T, Gooden GC, Johnson KN, Martinez RA, Petricoin EF, Pierobon M, O'Shaughnessy J, Osborne C, Schroeder MA, Ma DJ, Bernstein M, Sarkaria JN, Toms SA, et al. Abstract 991: Development and characterization of patient derived xenografts from central nervous system metastasis reveal minor clone expansion linked with aggressive tumor behavior Tumor Biology. DOI: 10.1158/1538-7445.Am2018-991 |
0.309 |
|
| 2018 |
Mitra SA, Mitra AP, Liu Y, Buckley JD, Triche TJ. Abstract 2066: The functional noncoding genome in childhood sarcomas plays important regulatory roles in tumor pathogenesis Tumor Biology. DOI: 10.1158/1538-7445.Am2018-2066 |
0.312 |
|
| 2018 |
Salhia B, Gooden G, Triche T. Clinical applications of cfDNA methylation in breast cancer Meta Gene. 17: S12. DOI: 10.1016/J.Mgene.2018.05.051 |
0.348 |
|
| 2017 |
Merchant AA, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche TJ, Druker BJ, Tyner JW, Gill PS. EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT. Blood Advances. 1: 1635-1644. PMID 29296810 DOI: 10.1182/Bloodadvances.2017005694 |
0.376 |
|
| 2017 |
Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nature Medicine. PMID 29227476 DOI: 10.1038/Nm.4439 |
0.305 |
|
| 2017 |
Colombo AR, Zubair A, Thiagarajan D, Nuzhdin S, Triche TJ, Ramsingh G. Suppression of Transposable Elements in Leukemic Stem Cells. Scientific Reports. 7: 7029. PMID 28765607 DOI: 10.1038/S41598-017-07356-9 |
0.39 |
|
| 2017 |
Chaudhry P, Singh M, Triche TJ, Guzman M, Merchant AA. GLI3 Repressor Determines Hedgehog Pathway Activation and is Required for Response to SMO Antagonist Glasdegib in AML. Blood. PMID 28487292 DOI: 10.1182/Blood-2016-05-718585 |
0.37 |
|
| 2017 |
Kang H, Nagy J, Samulak J, Triche T. Abstract 695: Targeted nanoparticle therapy for poor prognosis Ewing’s sarcoma Cancer Research. 77: 695-695. DOI: 10.1158/1538-7445.Am2017-695 |
0.307 |
|
| 2017 |
Biegel J, Triche T, Ostrow DG, Buckley J, Busse T, Gai X, Judkins A, Maglinte D, Raca G, Hiemenz M. Detection of Gene Fusions in Pediatric Hematologic Malignancies and Solid Tumors With the OncoKids Next Generation Sequencing Based Assay Cancer Genetics and Cytogenetics. 214: 41. DOI: 10.1016/J.Cancergen.2017.04.030 |
0.323 |
|
| 2016 |
Gopalakrishnan R, Matta H, Tolani B, Triche T, Chaudhary PM. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. Oncogene. 35: 1797-810. PMID 26119939 DOI: 10.1038/Onc.2015.245 |
0.355 |
|
| 2016 |
Ries RE, Bolouri H, Farrar JE, Lim EL, Triche TJ, Tarlock K, Auvil JG, Hirsch BA, Raimondi SC, Ma Y, Marra MA, Aplenc R, Guest EM, Kolb EA, Gamis AS, et al. Alteration of Chromatin Modifiers and Misregulation of Transcription Factors Define the Genomic Profile of Infant AML Blood. 128: 774-774. DOI: 10.1182/Blood.V128.22.774.774 |
0.352 |
|
| 2016 |
Farrar JE, Bolouri H, Ries RE, Triche TJ, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Auvil JG, Davidsen TM, Gesuwan P, Hermida LC, Kolb EA, et al. Marked Differences in the Genomic Landscape of Pediatric Compared to Adult Acute Myeloid Leukemia: A Report from the Children's Oncology Group and NCI/COG Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative Blood. 128: 595-595. DOI: 10.1182/Blood.V128.22.595.595 |
0.349 |
|
| 2016 |
Triche TJ, Farrar JE, Bolouri H, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Guidry Auvil JM, Davidsen TM, Gesuwan P, Hermida LC, Kolb EA, et al. Divergent Epigenomes in Pediatric and Adult Acute Myeloid Leukemia Implicate Cell of Origin and Transcriptional Silencing of Immune Responses As Sources of Clinically Relevant Heterogeneity: A Report from the Children's Oncology Group and NCI/COG Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative Blood. 128: 1046-1046. DOI: 10.1182/Blood.V128.22.1046.1046 |
0.372 |
|
| 2016 |
Mitra SA, Mitra AP, Buckley JD, Triche TJ. Abstract 2517: Ewing sarcoma associated long non-coding RNA determines neural cell fate of the tumors Cancer Research. 76: 2517-2517. DOI: 10.1158/1538-7445.Am2016-2517 |
0.443 |
|
| 2016 |
Xu T, Morrison G, Xu Y, Triche T, Buckley J, Goldkorn A. Abstract 1546: Differential gene expression analysis by NGS of primary tumor xenograft cells, circulating tumor cells, and metastasis cells purified from the same mouse hosts to identify drivers of cancer dissemination Cancer Research. 76: 1546-1546. DOI: 10.1158/1538-7445.Am2016-1546 |
0.424 |
|
| 2016 |
Triche TJ, Biegel J, Judkins A, Busse T, Wayne A, Bhojwani D, Asgharzadeh S, Oberley M, Parham D. Abstract 1384: A comprehensive gene panel for precise diagnosis and treatment of childhood cancer Cancer Research. 76: 1384-1384. DOI: 10.1158/1538-7445.Am2016-1384 |
0.314 |
|
| 2015 |
Hingorani P, Missiaglia E, Shipley J, Anderson JR, Triche TJ, Delorenzi M, Gastier-Foster J, Wing M, Hawkins DS, Skapek SX. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 4733-9. PMID 26473193 DOI: 10.1200/Jco.2015.33.15_Suppl.10510 |
0.339 |
|
| 2015 |
Venkatramani R, Triche TJ, Wang L, Shimada H, Mascarenhas L. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology. 37: e356-60. PMID 26056800 DOI: 10.1097/Mph.0000000000000382 |
0.353 |
|
| 2015 |
Volchenboum SL, Andrade J, Huang L, Barkauskas DA, Krailo M, Womer RB, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor ER. Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group. The Journal of Pathology. Clinical Research. 1: 83-94. PMID 26052443 DOI: 10.1002/cjp2.9 |
0.301 |
|
| 2015 |
Moore JB, Loeb DM, Hong KU, Sorensen PH, Triche TJ, Lee DW, Barbato MI, Arceci RJ. Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line. Frontiers in Cell and Developmental Biology. 3: 15. PMID 25806369 DOI: 10.3389/Fcell.2015.00015 |
0.389 |
|
| 2015 |
Kang MH, Wang J, Makena MR, Lee JS, Paz N, Hall CP, Song MM, Calderon RI, Cruz RE, Hindle A, Ko W, Fitzgerald JB, Drummond DC, Triche TJ, Reynolds CP. Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1139-50. PMID 25733708 DOI: 10.1158/1078-0432.Ccr-14-1882 |
0.324 |
|
| 2015 |
Chaudhry P, Singh M, Triche T, Jorapur A, Gill PS, Merchant A. Abstract 2090: GLI3 repressor levels determine Hedgehog pathway activity and predict response to Smoothened antagonist in acute myeloid leukemia Cancer Research. 75: 2090-2090. DOI: 10.1158/1538-7445.Am2015-2090 |
0.393 |
|
| 2015 |
Hu B, Liu S, Xu Y, Dempsey P, Strauss W, Wentzel K, Xu T, Pinski J, Dorff T, Triche T, Winer Jones J, Gill I, Quinn D, Goldkorn A. MP37-06 TARGETED SEQUENCING OF PROSTATE CANCER CIRCULATING TUMOR CELLS AND COMPARISON WITH MATCHED CELL FREE DNA AND PROSTATE TUMORS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1269 |
0.331 |
|
| 2014 |
Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer. Journal of the National Cancer Institute. 106. PMID 25344601 DOI: 10.1093/Jnci/Dju290 |
0.539 |
|
| 2014 |
Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF, Liao H, Wen X, Gerard J, Kim JS, Lopez Guerrero JA, ... ... Triche T, et al. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. Plos Genetics. 10: e1004475. PMID 25010205 DOI: 10.1371/Journal.Pgen.1004475 |
0.386 |
|
| 2014 |
Chiu CG, Nakamura Y, Chong KK, Huang SK, Kawas NP, Triche T, Elashoff D, Kiyohara E, Irie RF, Morton DL, Hoon DS. Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. Clinical Chemistry. 60: 873-85. PMID 24718909 DOI: 10.1373/Clinchem.2013.213611 |
0.351 |
|
| 2014 |
Shi J, Marconett CN, Duan J, Hyland PL, Li P, Wang Z, Wheeler W, Zhou B, Campan M, Lee DS, Huang J, Zhou W, Triche T, Amundadottir L, Warner A, et al. Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nature Communications. 5: 3365. PMID 24572595 DOI: 10.1038/Ncomms4365 |
0.547 |
|
| 2014 |
Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, et al. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer and Prostatic Diseases. 17: 64-9. PMID 24145624 DOI: 10.1038/Pcan.2013.49 |
0.492 |
|
| 2014 |
Capone S, Triche TJ, In G, Weisenberger DJ, Berman BP, Ramsingh G. Whole-genome bisulfite sequencing of a complex karyotype AML and identification of regulatory aberrations distinct from normal karyotype AML. Journal of Clinical Oncology. 32: 11075-11075. DOI: 10.1200/Jco.2014.32.15_Suppl.11075 |
0.307 |
|
| 2014 |
Gopalakrishnan R, Matta H, Tolani B, Triche TJ, Chaudhary P. Immunomodulatory Drugs Are Efficacious Against Primary Effusion Lymphoma By Targeting IKZF1, IRF4 and MYC in a CRBN-Dependent Manner and Are Synergistic with BRD4 Inhibitors Blood. 124: 3109-3109. DOI: 10.1182/Blood.V124.21.3109.3109 |
0.338 |
|
| 2014 |
Volchenboum SL, Andrade J, Barkauskas DA, Krailo M, Sposto R, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor E. Abstract A72: Do prognostic gene signatures exist in Ewing sarcoma? A report from the Children's Oncology Group Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A72 |
0.435 |
|
| 2014 |
Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Abstract A43: Therapeutic importance of a long noncoding RNA in Ewing sarcoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A43 |
0.439 |
|
| 2014 |
Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Abstract A16: Discovery and validation of novel prognostic genomic signatures in rhabdomyosarcoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A16 |
0.383 |
|
| 2014 |
Kang H, Shahbazian V, Schafenacker A, Nagy J, Triche T. Abstract 5424: Development of selective therapy of childhood ALL and Ewing's sarcoma using targeted-hybrid polymerized liposomal nanoparticles (HPLN) Cancer Research. 74: 5424-5424. DOI: 10.1158/1538-7445.Am2014-5424 |
0.349 |
|
| 2014 |
Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Abstract 4973: Long non-coding RNA promotes metastatic behavior in Ewing sarcoma Cancer Research. 74: 4973-4973. DOI: 10.1158/1538-7445.Am2014-4973 |
0.423 |
|
| 2014 |
Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Abstract 4730: Identification of novel prognostic signatures in rhabdomyosarcoma by whole transcriptome expression profiling: A discovery and validation study Cancer Research. 74: 4730-4730. DOI: 10.1158/1538-7445.Am2014-4730 |
0.382 |
|
| 2014 |
Kang MH, Song MM, Makena M, Lee J, Hall CP, Hindle A, Ko W, Paz N, Fitzgerald J, Drummond DC, Triche TJ, Reynolds CP. Abstract 3972: Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewings family tumor xenografts is associated with high exposure of tumor to drug and highSLFN11expression Cancer Research. 74: 3972-3972. DOI: 10.1158/1538-7445.Am2014-3972 |
0.378 |
|
| 2014 |
Shi J, Marconett C, Duan J, Hyland P, Li P, Wang Z, Wheeler W, Campan M, Huang J, Zhou W, Triche T, Amundadottir L, Hutchinson A, Chen P, Zhou B, et al. Abstract 287: Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue Cancer Research. 74: 287-287. DOI: 10.1158/1538-7445.Am2014-287 |
0.552 |
|
| 2014 |
Mitra A, Lam L, Ghadessi M, Erho N, Vergara I, Alshalalfa M, Haddad Z, Sierocinski T, Triche T, Skinner E, Davicioni E, Daneshmand S, Black P. 898 Discovery and validation of a novel expression signature for predicting recurrence in high-risk bladder cancer post-cystectomy European Urology Supplements. 13: e898. DOI: 10.1016/S1569-9056(14)60884-8 |
0.505 |
|
| 2014 |
Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. MP39-09 A COMBINATION OF GENOMIC MARKERS AND CLINICAL VARIABLES PROVIDES SUPERIOR PROGNOSTIC PERFORMANCE IN HIGH-RISK BLADDER CANCER FOLLOWING CYSTECTOMY Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1324 |
0.536 |
|
| 2013 |
Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJ, Triche TJ, Schaeffer EM, Feng FY. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 52. PMID 28137052 DOI: 10.1200/Jco.2013.31.15_Suppl.5033 |
0.51 |
|
| 2013 |
Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJ, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, Vergara IA, Triche TJ, et al. Validation of a genomic classifier that predicts metastatic disease progression in men with high-risk pathologic features postprostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 36. PMID 28136987 DOI: 10.1200/Jco.2013.31.6_Suppl.36 |
0.517 |
|
| 2013 |
May WA, Grigoryan RS, Keshelava N, Cabral DJ, Christensen LL, Jenabi J, Ji L, Triche TJ, Lawlor ER, Reynolds CP. Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines. Plos One. 8: e80060. PMID 24312454 DOI: 10.1371/Journal.Pone.0080060 |
0.327 |
|
| 2013 |
Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Triche TJ, Malik R, Bedenis R, McGregor N, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nature Genetics. 45: 1392-8. PMID 24076601 DOI: 10.1038/Ng.2771 |
0.513 |
|
| 2013 |
Wiseman SM, Haddad Z, Walker B, Vergara IA, Sierocinski T, Crisan A, Ghadessi M, Dao P, Zimmermann B, Triche TJ, Erho N, Davicioni E. Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis. The Journal of Clinical Endocrinology and Metabolism. 98: 4072-9. PMID 23928671 DOI: 10.1210/Jc.2013-1991 |
0.519 |
|
| 2013 |
Wilson RA, Teng L, Bachmeyer KM, Bissonnette ML, Husain AN, Parham DM, Triche TJ, Wing MR, Gastier-Foster JM, Barr FG, Hawkins DS, Anderson JR, Skapek SX, Volchenboum SL. A novel algorithm for simplification of complex gene classifiers in cancer. Cancer Research. 73: 5625-32. PMID 23913937 DOI: 10.1158/0008-5472.Can-13-0324 |
0.319 |
|
| 2013 |
Fam HK, Walton C, Mitra SA, Chowdhury M, Osborne N, Choi K, Sun G, Wong PC, O'Sullivan MJ, Turashvili G, Aparicio S, Triche TJ, Bond M, Pallen CJ, Boerkoel CF. TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells. Molecular Cancer Research : McR. 11: 1179-92. PMID 23913164 DOI: 10.1158/1541-7786.Mcr-12-0575 |
0.347 |
|
| 2013 |
St Laurent G, Shtokalo D, Dong B, Tackett MR, Fan X, Lazorthes S, Nicolas E, Sang N, Triche TJ, McCaffrey TA, Xiao W, Kapranov P. VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer. Genome Biology. 14: R73. PMID 23876380 DOI: 10.1186/Gb-2013-14-7-R73 |
0.405 |
|
| 2013 |
Erho N, Crisan A, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche TJ, Black PC, et al. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. Plos One. 8: e66855. PMID 23826159 DOI: 10.1371/Journal.Pone.0066855 |
0.557 |
|
| 2013 |
Karnes RJ, Bergstralh EJ, Davicioni E, Ghadessi M, Buerki C, Mitra AP, Crisan A, Erho N, Vergara IA, Lam LL, Carlson R, Thompson DJ, Haddad Z, Zimmermann B, Sierocinski T, ... Triche TJ, et al. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. The Journal of Urology. 190: 2047-53. PMID 23770138 DOI: 10.1016/J.Juro.2013.06.017 |
0.524 |
|
| 2013 |
Mendoza-Naranjo A, El-Naggar A, Wai DH, Mistry P, Lazic N, Ayala FR, da Cunha IW, Rodriguez-Viciana P, Cheng H, Tavares Guerreiro Fregnani JH, Reynolds P, Arceci RJ, Nicholson A, Triche TJ, Soares FA, et al. ERBB4 confers metastatic capacity in Ewing sarcoma. Embo Molecular Medicine. 5: 1019-34. PMID 23681745 DOI: 10.1002/Emmm.201202343 |
0.372 |
|
| 2013 |
Triche TJ, Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Research. 41: e90. PMID 23476028 DOI: 10.1093/Nar/Gkt090 |
0.528 |
|
| 2013 |
Christensen L, Joo J, Lee S, Wai D, Triche TJ, May WA. FOXM1 is an oncogenic mediator in Ewing Sarcoma. Plos One. 8: e54556. PMID 23365673 DOI: 10.1371/Journal.Pone.0054556 |
0.404 |
|
| 2013 |
Mitra AP, Erho N, Lam LL, Vergara IA, Sierocinski T, Zimmermann B, Haddad Z, Ghadessi M, Crisan A, Triche TJ, Daneshmand S, Buerki C, Davicioni E, Black PC. Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer. Journal of Clinical Oncology. 31: 4542-4542. DOI: 10.1200/Jco.2013.31.15_Suppl.4542 |
0.532 |
|
| 2013 |
Liu SV, Dempsey PW, Strauss W, Xu Y, Xu T, Pinski JK, Dorff TB, Quinn DI, Triche TJ, Winer-Jones J, De Fusco A, McMurdie J, Goldkorn A. Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) in hormone-sensitive prostate cancer (HSPC). Journal of Clinical Oncology. 31: 11040-11040. DOI: 10.1200/Jco.2013.31.15_Suppl.11040 |
0.37 |
|
| 2013 |
Triche T, Capone S, Merchant A, Chaudhary P, Ramsingh G. DNA Methylation Changes In Aging Human CD34+ Cells Coincide With Hotspots Of Disordered Methylation In AML At Imprinted and Allelically Methylated Regions Blood. 122: 1193-1193. DOI: 10.1182/Blood.V122.21.1193.1193 |
0.307 |
|
| 2013 |
Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RA, Triche TJ. Abstract PR04: Genomic and epigenomic interactions of an Ewing sarcoma-specific long noncoding RNA Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-Pr04 |
0.421 |
|
| 2013 |
Liu SV, Dempsey PW, Strauss W, Xu Y, Xu T, Winer-Jones J, Triche TJ, Quinn DI, McMurdie J, Defusco A, Goldkorn A. Abstract LB-227: Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) and matched primary tumors. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-227 |
0.388 |
|
| 2013 |
Kang H, Shahbazian V, Nagy J, Triche T. Abstract 2750: Targeted therapy of childhood ALL and Ewing's sarcoma using antiCD19 (antiCD99)-Hybrid Polymerized Liposomal Nanoparticles (HPLN). Cancer Research. 73: 2750-2750. DOI: 10.1158/1538-7445.Am2013-2750 |
0.336 |
|
| 2013 |
Moore JB, Lee DW, Barbato M, Triche T, Wai D, Arceci RJ. Abstract 2646: Ewing sarcoma-derived iPS cell lines are resistant to chemotherapy but exhibit EWS-FLI1-independent, increased rapamycin sensitivity. Cancer Research. 73: 2646-2646. DOI: 10.1158/1538-7445.Am2013-2646 |
0.404 |
|
| 2013 |
Mitra AP, Haydel D, Mitra SA, Dunne J, Silveria S, Wang L, Triche TJ. Abstract 24: Diagnosing small round cell tumors using whole transcriptome expression profiling. Cancer Research. 73: 24-24. DOI: 10.1158/1538-7445.Am2013-24 |
0.381 |
|
| 2013 |
Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Abstract 1823: Influence of a long non-coding RNA on epigenetic, genetic and phenotypic changes in Ewing sarcoma. Cancer Research. 73: 1823-1823. DOI: 10.1158/1538-7445.Am2013-1823 |
0.445 |
|
| 2013 |
Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Abstract 17: Prognostic value of coding and non-coding genomic meta-features in rhabdomyosarcoma. Cancer Research. 73: 17-17. DOI: 10.1158/1538-7445.Am2013-17 |
0.364 |
|
| 2013 |
Liu S, Dempsey P, Strauss W, Xu Y, Xu T, Triche T, Quinn D, Goldkorn A. MC13-0020 Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) and matched primary tumors European Journal of Cancer. 49: S17. DOI: 10.1016/S0959-8049(13)70135-7 |
0.327 |
|
| 2013 |
Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJ, Triche TJ, Feng FY, Schaeffer EM. 2240 PERFORMANCE OF A GENOMIC CLASSIFIER THAT PREDICTS METASTATIC DISEASE PROGRESSION IN MEN WITH BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2149 |
0.491 |
|
| 2013 |
Dolginow D, Crisan A, Buerki C, Ghadessi M, Mitra AP, Erho N, Vergara IA, Haddad Z, Sierocinski T, Triche TJ, Davicioni E. 2230 EVALUATION OF A GENOMIC CLASSIFIER FOR IMPROVED RISK STRATIFICATION IN PROSTATE CANCER PATIENTS WITH SPECIFIC ADVERSE PATHOLOGIES AFTER SURGERY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2139 |
0.49 |
|
| 2013 |
Ross A, Ghadessi M, Crisan A, Buerki C, Erho N, Vergara I, Haddad Z, Harko S, Mitra A, Thompson D, Triche T, Davicioni E, Schaeffer E. 2229 COMPARISON OF CLINICAL AND GENOMIC MODELS FOR PREDICTION OF RAPID METASTATIC DISEASE AFTER RADICAL PROSTATECTOMY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2138 |
0.485 |
|
| 2013 |
Karnes RJ, Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJS, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, ... ... Triche TJ, et al. 2130 Validation Of A Genomic Classifier That Predicts Metastatic Disease Progression In Men With High Risk Pathological Features Post-Prostatectomy The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2039 |
0.494 |
|
| 2013 |
Feng F, Ghadessi M, Davicioni E, Crisan A, Erho N, Mitra A, Triche T, Jenkins R, Ross A, Schaeffer E. Validation of a Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post-Radical Prostatectomy International Journal of Radiation Oncology*Biology*Physics. 87: S125. DOI: 10.1016/J.Ijrobp.2013.06.323 |
0.491 |
|
| 2012 |
Jenkins RB, Bergstralh EJ, Davicioni E, Karnes RJ, Ballman KV, Fink S, Black PC, Ghadessi M, Triche TJ, Klee GG, Kollmeyer TM, Vergara IA, Crisan A, Erho N, Sierocinski T, et al. Validation of a genomic-clinical classifier model for predicting clinical recurrence of patients with localized prostate cancer in a high-risk population. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 175. PMID 28143156 DOI: 10.1200/jco.2012.30.5_suppl.175 |
0.436 |
|
| 2012 |
Vergara IA, Buerki C, Ghadessi M, Crisan A, Sierocinski T, Haddad Z, Zimmermann B, Harko S, Sosu-Sedzorme W, Triche TJ, Jenkins RB, Davicioni E. Development and validation of a digital Gleason score biomarker signature for risk stratification of patients with prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 40. PMID 28142490 DOI: 10.1200/Jco.2012.30.30_Suppl.40 |
0.506 |
|
| 2012 |
Vergara IA, Buerki C, Ghadessi M, Crisan A, Sierocinski T, Haddad Z, Zimmermann B, Harko S, Sosu-Sedzorme W, Triche TJ, Davicioni E. Discovery of a biomarker signature that predicts upgrading or upstaging in patients with low-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 37. PMID 28142405 DOI: 10.1200/Jco.2012.30.30_Suppl.37 |
0.503 |
|
| 2012 |
Jenkins RB, Bergstralh EJ, Davicioni E, Karnes RJ, Ballman KV, Fink S, Black PC, Ghadessi M, Triche TJ, Klee GG, Kollmeyer TM, Vergara IA, Crisan A, Erho N, Sierocinski T, et al. Validation of a genomic-clinical classifier model for predicting clinical recurrence of patients with localized prostate cancer in a high-risk population. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 175. PMID 27968097 DOI: 10.1200/Jco.2012.30.5_Suppl.175 |
0.501 |
|
| 2012 |
Erho N, Buerki C, Triche TJ, Davicioni E, Vergara IA. Transcriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancer. Journal of Oncology. 2012: 541353. PMID 22956952 DOI: 10.1155/2012/541353 |
0.539 |
|
| 2012 |
Wu CC, D'Argenio D, Asgharzadeh S, Triche T. TARGETgene: a tool for identification of potential therapeutic targets in cancer. Plos One. 7: e43305. PMID 22952662 DOI: 10.1371/Journal.Pone.0043305 |
0.314 |
|
| 2012 |
Gadd S, Beezhold P, Jennings L, George D, Leuer K, Huang CC, Huff V, Tognon C, Sorensen PH, Triche T, Coffin CM, Perlman EJ. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. The Journal of Pathology. 228: 119-30. PMID 22374738 DOI: 10.1002/Path.4010 |
0.352 |
|
| 2012 |
Vergara IA, Erho N, Triche TJ, Ghadessi M, Crisan A, Sierocinski T, Black PC, Buerki C, Davicioni E. Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers. Frontiers in Genetics. 3: 23. PMID 22371711 DOI: 10.3389/Fgene.2012.00023 |
0.538 |
|
| 2012 |
Murphree AL, Triche TJ. An epigenomic mechanism in retinoblastoma: the end of the story? Genome Medicine. 4: 15. PMID 22364211 DOI: 10.1186/Gm314 |
0.328 |
|
| 2012 |
Mitra SA, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. Frontiers in Genetics. 3: 17. PMID 22363342 DOI: 10.3389/Fgene.2012.00017 |
0.346 |
|
| 2012 |
Kaddis JS, Wai DH, Bowers J, Hartmann N, Baeriswyl L, Bajaj S, Anderson MJ, Getts RC, Triche TJ. Influence of RNA labeling on expression profiling of microRNAs. The Journal of Molecular Diagnostics : Jmd. 14: 12-21. PMID 22074760 DOI: 10.1016/J.Jmoldx.2011.08.005 |
0.742 |
|
| 2012 |
Ng TL, Leprivier G, Robertson MD, Chow C, Martin MJ, Laderoute KR, Davicioni E, Triche TJ, Sorensen PH. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death and Differentiation. 19: 501-10. PMID 21941369 DOI: 10.1038/Cdd.2011.119 |
0.486 |
|
| 2012 |
Skapek S, Anderson JR, Barr FG, Bridge JA, Gastier-Foster JM, Parham D, Rudzinski ER, Triche TJ, Hawkins DS. Relationship of fusion protein status and outcome for children with intermediate-risk rhabdomyosarcoma: A Children's Oncology Group report. Journal of Clinical Oncology. 30: 9535-9535. DOI: 10.1200/Jco.2012.30.15_Suppl.9535 |
0.32 |
|
| 2012 |
Buerki C, Mitra AP, Black PC, Ghadessi M, Bergstralh EJ, Erho N, Carlson R, Crisan A, Sierocinski T, Zimmermann B, Haddad Z, Vergara IA, Ballman KV, Klee GG, Fink S, ... ... Triche TJ, et al. Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer. Journal of Clinical Oncology. 30: 4565-4565. DOI: 10.1200/Jco.2012.30.15_Suppl.4565 |
0.519 |
|
| 2012 |
Berman BP, Weisenberger DJ, Hinoue T, Noushmehr H, Liu Y, Aman JF, Hinoue T, Shen H, Malik S, Mahurkar S, Triche T, Ramjan Z, Nicolet CM, Van Den Berg D, Cope L, et al. Exploring the cancer methylome Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S6-O24 |
0.35 |
|
| 2012 |
Crisan A, Davicioni E, Karnes RJ, Jenkins RB, Ghadessi MH, Buerki C, Bergstrahl EJ, Erho N, Vergara IA, Ballman KV, Black PC, Triche TJ. Abstract PR4: Biochemical recurrence is not a definitive surrogate endpoint for development of clinically useful predictive models for post-prostatectomy patients Cancer Research. 72: PR4-PR4. DOI: 10.1158/1538-7445.Prca2012-Pr4 |
0.47 |
|
| 2012 |
Erho N, Sierocinski T, Davicioni E, Jenkins RB, Gadhessi M, Buerki C, Vergara IA, Crisan A, Haddad Z, Zimmermann B, Mitra A, Triche TJ. Abstract B46: Identification of biomarkers for stratification of Gleason score 7 patients using whole-transcriptome expression profiling Cancer Research. 72: B46-B46. DOI: 10.1158/1538-7445.Prca2012-B46 |
0.486 |
|
| 2012 |
Mitra AP, Triche TJ, Mitra SA, Buckley JD, Sorensen PHB, Reynolds CP, Arceci RJ, Milos P, St. Laurent G, Kapranov P. Abstract B6: Human genome contains a large number of very long intergenic transcribed regions, some of which are associated with cancer outcome Cancer Research. 72: B6-B6. DOI: 10.1158/1538-7445.Nonrna12-B6 |
0.362 |
|
| 2012 |
Mitra SA, Wai DH, May WA, Buckley JD, Kapranov P, Arceci RJ, Triche TJ. Abstract B18: The transcribed non-coding genome modulates the biology of Ewing sarcoma family of tumors Cancer Research. 72: B18-B18. DOI: 10.1158/1538-7445.Nonrna12-B18 |
0.442 |
|
| 2012 |
Mitra AP, Buckley JD, Mitra SA, Davicioni E, Anderson JR, Kapranov P, Skapek SX, Hawkins DS, Triche TJ. Abstract A23: A non-coding RNA panel predicts intermediate-risk childhood rhabdomyosarcoma prognosis better than standard pathologic criteria and coding genes Cancer Research. 72: A23-A23. DOI: 10.1158/1538-7445.Nonrna12-A23 |
0.536 |
|
| 2012 |
Mitra AP, Buckley JD, Mitra SA, Davicioni E, Anderson JR, Kapranov P, Skapek SX, Hawkins DS, Triche TJ. Abstract 5581: A non-coding RNA panel is prognostically superior to standard pathologic criteria and coding transcripts in rhabdomyosarcoma Cancer Research. 72: 5581-5581. DOI: 10.1158/1538-7445.Am2012-5581 |
0.54 |
|
| 2012 |
Mendoza-Naranjo A, Wai DH, Farrar JE, Zhu Q, Mistry P, Lazic N, Ayala FRR, Cunha IWd, Arceci RJ, Soares FA, Triche TJ, Strauss SJ, Sorensen PH. Abstract 431: ErbB4 is a novel driver of metastasis and anoikis resistance in Ewing's sarcoma Cancer Research. 72: 431-431. DOI: 10.1158/1538-7445.Am2012-431 |
0.421 |
|
| 2012 |
Mitra SA, Wai DH, Buckley J, Kapranov P, Arceci RJ, Triche TJ. Abstract 1441: Role of a long non-coding RNA in oncogenesis of Ewing sarcoma Cancer Research. 72: 1441-1441. DOI: 10.1158/1538-7445.Am2012-1441 |
0.436 |
|
| 2011 |
Rodeberg DA, Garcia-Henriquez N, Lyden ER, Davicioni E, Parham DM, Skapek SX, Hayes-Jordan AA, Donaldson SS, Brown KL, Triche TJ, Meyer WH, Hawkins DS. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1304-11. PMID 21357792 DOI: 10.1200/Jco.2010.29.4611 |
0.472 |
|
| 2011 |
Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche TJ, Sposto R, Lawlor ER. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 56-66. PMID 21047978 DOI: 10.1158/1078-0432.Ccr-10-1417 |
0.382 |
|
| 2011 |
Kang HG, Liu XF, Sorensen PH, Triche TJ. Abstract 5336: Macrophage migration inhibitory factor (MIF) plays roles in proliferation, survival and migration of Ewing tumor cells through the activation of several tyrosine kinases Cancer Research. 71: 5336-5336. DOI: 10.1158/1538-7445.Am2011-5336 |
0.396 |
|
| 2011 |
Xu G, Wang H, Rainusso NC, Flores RJ, Triche T, Man T, Lau CC. Abstract 5331: CHK1 inhibition enhances chemosensitivity of p53 deficient osteosarcoma cells Cancer Research. 71: 5331-5331. DOI: 10.1158/1538-7445.Am2011-5331 |
0.411 |
|
| 2011 |
Wai DH, Wing MR, Kneile K, Moyer Y, Buckley JD, Seeger RC, Hawkins DS, Skapek SX, Triche TJ. Abstract 4350: Translating diagnostic gene expression profiles for pediatric solid tumors Cancer Research. 71: 4350-4350. DOI: 10.1158/1538-7445.Am2011-4350 |
0.366 |
|
| 2011 |
Heuston EF, Farrar JE, Triche T, Buckley J, Wai DH, Ochs M, Considine M, Reaman G, Arceci RJ. Abstract 2001: 5-Aza-2’-deoxycytidine and cytarabine mediate distinct effects on clonogenic growth, genome wide methylation and RNA expression in AML Cellular and Molecular Biology. 71: 2001-2001. DOI: 10.1158/1538-7445.Am2011-2001 |
0.306 |
|
| 2011 |
Bajaj SV, Wai DH, Buckley JD, Kapranov P, Lawlor ER, Triche TJ. Abstract 1182: A large non-coding RNA that is characteristic of Ewing sarcoma family of tumors Cancer Research. 71: 1182-1182. DOI: 10.1158/1538-7445.Am2011-1182 |
0.789 |
|
| 2011 |
Kapranov P, Laurent GS, Raz T, Ozsolak F, Reynolds CP, Sorensen PH, Reaman G, Milos PM, Arceci RJ, Thompson JF, Triche TJ. Abstract 1177: The majority of total nuclear-encoded non-ribosomal RNA in human normal and tumor cells is “dark matter” unannotated RNA Cancer Research. 71: 1177-1177. DOI: 10.1158/1538-7445.Am2011-1177 |
0.342 |
|
| 2010 |
Kapranov P, St Laurent G, Raz T, Ozsolak F, Reynolds CP, Sorensen PH, Reaman G, Milos P, Arceci RJ, Thompson JF, Triche TJ. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. Bmc Biology. 8: 149. PMID 21176148 DOI: 10.1186/1741-7007-8-149 |
0.312 |
|
| 2010 |
Potratz JC, Saunders DN, Wai DH, Ng TL, McKinney SE, Carboni JM, Gottardis MM, Triche TJ, Jürgens H, Pollak MN, Aparicio SA, Sorensen PH. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas. Cancer Research. 70: 8770-81. PMID 20959493 DOI: 10.1158/0008-5472.Can-10-1093 |
0.359 |
|
| 2010 |
Molyneux SD, Di Grappa MA, Beristain AG, McKee TD, Wai DH, Paderova J, Kashyap M, Hu P, Maiuri T, Narala SR, Stambolic V, Squire J, Penninger J, Sanchez O, Triche TJ, et al. Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. The Journal of Clinical Investigation. 120: 3310-25. PMID 20697156 DOI: 10.1172/Jci42391 |
0.383 |
|
| 2010 |
Abdueva D, Wing M, Schaub B, Triche T, Davicioni E. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. The Journal of Molecular Diagnostics : Jmd. 12: 409-17. PMID 20522636 DOI: 10.2353/Jmoldx.2010.090155 |
0.529 |
|
| 2010 |
Kang HG, Jenabi JM, Liu XF, Reynolds CP, Triche TJ, Sorensen PH. Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells. Molecular Cancer Therapeutics. 9: 1396-407. PMID 20423994 DOI: 10.1158/1535-7163.Mct-09-0604 |
0.355 |
|
| 2010 |
Jiang X, Gwye Y, Russell D, Cao C, Douglas D, Hung L, Kovar H, Triche TJ, Lawlor ER. CD133 expression in chemo-resistant Ewing sarcoma cells. Bmc Cancer. 10: 116. PMID 20346143 DOI: 10.1186/1471-2407-10-116 |
0.364 |
|
| 2010 |
van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1989-94. PMID 20308669 DOI: 10.1200/Jco.2009.24.5845 |
0.343 |
|
| 2010 |
Luo P, Yang X, Ying M, Chaudhry P, Wang A, Shimada H, May WA, Adams GB, Mock D, Triche TJ, He Q, Wu L. Retinoid-suppressed phosphorylation of RARα mediates the differentiation pathway of osteosarcoma cells Oncogene. 29: 2772-2783. PMID 20190807 DOI: 10.1038/Onc.2010.50 |
0.337 |
|
| 2010 |
Davicioni E, Anderson JR, Buckley JD, Meyer WH, Triche TJ. Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1240-6. PMID 20124188 DOI: 10.1200/Jco.2008.21.1268 |
0.538 |
|
| 2010 |
Wang A, Alimova IN, Luo P, Jong A, Triche TJ, Wu L. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 833-43. PMID 19917671 DOI: 10.1096/Fj.09-142976 |
0.35 |
|
| 2010 |
Kang H, Liu XF, Sorensen PH, Triche TJ. Abstract LB-388: Macrophage migration inhibitory factor (MIF) plays a role in proliferation, differentiation, and survival of Ewing tumor cells through the activation of several kinases Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-388 |
0.399 |
|
| 2010 |
Scannell CA, Abdueva D, Ji L, Levetzow Cv, Sposto R, Triche TJ, Lawlor ER. Abstract 4640: High expression of the stem cell marker LGR5 is associated with a poor clinical outcome in patients with Ewing's sarcoma Cancer Research. 70: 4640-4640. DOI: 10.1158/1538-7445.Am10-4640 |
0.418 |
|
| 2010 |
Wai DH, Wu D, Wing MR, Arceci RJ, Reynolds CP, Sorensen PH, Reamon GH, Milos PM, Lawlor ER, Buckley JD, Kapranov P, Triche TJ. Abstract 4087: Large intergenic noncoding RNAs associated with Ewing sarcoma family of tumors Cancer Research. 70: 4087-4087. DOI: 10.1158/1538-7445.Am10-4087 |
0.441 |
|
| 2010 |
Potratz J, Saunders D, Wai D, Reynolds CP, Buckley JD, Arceci RJ, Reaman GH, Triche TJ, Jürgens H, Pollak M, Sorensen PH. Abstract 3422: Synthetic lethal siRNA screening reveals novel modifiers of insulin-like growth factor-1 receptor (IGF1R) inhibitor activity in childhood sarcomas Cancer Research. 70: 3422-3422. DOI: 10.1158/1538-7445.Am10-3422 |
0.355 |
|
| 2010 |
Bajaj SV, Shahbazian V, Anderson MJ, Triche TJ. Abstract 3419: NOS1 imparts a survival benefit to PAX-FKHR expressing alveolar rhabdomyosarcomas Cancer Research. 70: 3419-3419. DOI: 10.1158/1538-7445.Am10-3419 |
0.784 |
|
| 2010 |
Mendoza M, Ren L, Davicioni E, Wai D, Triche T, Khanna C. Abstract 2357: Defining the Ezrin-CLIC4 interaction in osteosarcoma Cancer Research. 70: 2357-2357. DOI: 10.1158/1538-7445.Am10-2357 |
0.527 |
|
| 2010 |
Cozen W, Wang J, Siegmund K, Triche T, Weisenberger D, Berg DVD, Hamilton A, Hwang A, Mack TM. Abstract 155: A comparison of DNA methylation in identical twins discordant for Hodgkin lymphoma Cancer Research. 70: 155-155. DOI: 10.1158/1538-7445.Am10-155 |
0.543 |
|
| 2010 |
Wu C, Asgharzadeh S, D'Argenio D, Triche T. Abstract 109: Network-based model to identify potential therapeutic targets in breast, colon, and lung cancers Cancer Research. 70: 109-109. DOI: 10.1158/1538-7445.Am10-109 |
0.362 |
|
| 2009 |
Paoloni M, Davis S, Lana S, Withrow S, Sangiorgi L, Picci P, Hewitt S, Triche T, Meltzer P, Khanna C. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression Bmc Genomics. 10: 625. PMID 20028558 DOI: 10.1186/1471-2164-10-625 |
0.379 |
|
| 2009 |
Hu K, Lee C, Qiu D, Fotovati A, Davies A, Abu-Ali S, Wai D, Lawlor ER, Triche TJ, Pallen CJ, Dunn SE. Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas. Molecular Cancer Therapeutics. 8: 3024-35. PMID 19887553 DOI: 10.1158/1535-7163.Mct-09-0365 |
0.389 |
|
| 2009 |
Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, Sorokin A, Ovchinnikov LP, Davicioni E, Triche TJ, Sorensen PH. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell. 15: 402-15. PMID 19411069 DOI: 10.1016/J.Ccr.2009.03.017 |
0.54 |
|
| 2009 |
Davicioni E, Anderson MJ, Finckenstein FG, Lynch JC, Qualman SJ, Shimada H, Schofield DE, Buckley JD, Meyer WH, Sorensen PH, Triche TJ. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. The American Journal of Pathology. 174: 550-64. PMID 19147825 DOI: 10.2353/Ajpath.2009.080631 |
0.546 |
|
| 2009 |
Heuston E, Farrar JE, Triche T, Buckley J, Sorensen P, Reynolds CP, Reaman G, Yegnasubramanian V, Arceci RJ. Selective and Titratable Effects On AML Genome Wide Methylation Patterning, Transcription and Clonogenicity Using Very Low Concentrations of 5-Aza-2'deoxycytidine. Blood. 114: 2385-2385. DOI: 10.1182/Blood.V114.22.2385.2385 |
0.33 |
|
| 2008 |
Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI, Triche TJ, Shimada H, Anderson MJ. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Research. 68: 6587-97. PMID 18701482 DOI: 10.1158/0008-5472.Can-08-0859 |
0.404 |
|
| 2008 |
Douglas D, Hsu JH, Hung L, Cooper A, Abdueva D, van Doorninck J, Peng G, Shimada H, Triche TJ, Lawlor ER. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Research. 68: 6507-15. PMID 18701473 DOI: 10.1158/0008-5472.Can-07-6152 |
0.389 |
|
| 2008 |
Zwerner JP, Joo J, Warner KL, Christensen L, Hu-Lieskovan S, Triche TJ, May WA. The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene. 27: 3282-91. PMID 18084326 DOI: 10.1038/Sj.Onc.1210991 |
0.396 |
|
| 2007 |
Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK, Rogerio JW, Triche TJ, He Q, Wu L. Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells. Stem Cells (Dayton, Ohio). 25: 2628-37. PMID 17628022 DOI: 10.1634/Stemcells.2007-0264 |
0.317 |
|
| 2007 |
Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide. Journal of the National Cancer Institute. 99: 1107-19. PMID 17623797 DOI: 10.1093/Jnci/Djm044 |
0.523 |
|
| 2007 |
Parham DM, Qualman SJ, Teot L, Barr FG, Morotti R, Sorensen PH, Triche TJ, Meyer WH. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. The American Journal of Surgical Pathology. 31: 895-901. PMID 17527077 DOI: 10.1097/01.Pas.0000213436.99492.51 |
0.308 |
|
| 2007 |
Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Research. 67: 3094-105. PMID 17409416 DOI: 10.1158/0008-5472.Can-06-3259 |
0.331 |
|
| 2007 |
Tedeschi-Blok N, Buckley J, Varma R, Triche TJ, Hinton DR. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology. 114: 99-103. PMID 17198853 DOI: 10.1016/J.Ophtha.2006.07.043 |
0.743 |
|
| 2006 |
Wang JG, Barsky LW, Davicioni E, Weinberg KI, Triche TJ, Zhang XK, Wu L. Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2142-4. PMID 16935935 DOI: 10.1096/Fj.06-5900Fje |
0.519 |
|
| 2006 |
Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ, Anderson MJ. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Research. 66: 6936-46. PMID 16849537 DOI: 10.1158/0008-5472.Can-05-4578 |
0.574 |
|
| 2006 |
Yu Y, Davicioni E, Triche TJ, Merlino G. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Research. 66: 1982-9. PMID 16488997 DOI: 10.1158/0008-5472.Can-05-2360 |
0.583 |
|
| 2005 |
Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Research. 65: 8984-92. PMID 16204072 DOI: 10.1158/0008-5472.Can-05-0565 |
0.338 |
|
| 2005 |
Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J, Johnson M, Davino N, Murray J, Helman L, Meyer W, Triche T, Wong KK, Lau CC. Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Research. 65: 8142-50. PMID 16166288 DOI: 10.1158/0008-5472.Can-05-0985 |
0.338 |
|
| 2005 |
Yanagawa B, Taylor L, Deisher TA, Ng R, Schreiner GF, Triche TJ, Yang D, McManus BM. Affymetrix oligonucleotide analysis of gene expression in the injured heart. Methods in Molecular Medicine. 112: 305-20. PMID 16010026 DOI: 10.1385/1-59259-879-X:305 |
0.335 |
|
| 2005 |
Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Research. 65: 4633-44. PMID 15930281 DOI: 10.1158/0008-5472.Can-04-2857 |
0.408 |
|
| 2005 |
Heidel JD, Hu-Lieskovan S, Bartlett DW, Triche TJ, Davis ME. 70. Systemic Administration of siRNA Against EWS-FLI1 Using a Targeted, Non-Viral Formulation Inhibits Growth in a Disseminated Murine Model of Ewing's Sarcoma Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.048 |
0.392 |
|
| 2004 |
Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME. Lack of interferon response in animals to naked siRNAs. Nature Biotechnology. 22: 1579-82. PMID 15558046 DOI: 10.1038/Nbt1038 |
0.489 |
|
| 2004 |
Zhang J, Hu S, Schofield DE, Sorensen PH, Triche TJ. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas. Cancer Research. 64: 6026-34. PMID 15342383 DOI: 10.1158/0008-5472.Can-03-2594 |
0.507 |
|
| 2004 |
Zhang S, He Q, Peng H, Tedeschi-Blok N, Triche TJ, Wu L. MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G1 arrest and neurite outgrowth. Cancer Research. 64: 2977-83. PMID 15126328 DOI: 10.1158/0008-5472.Can-03-4018 |
0.771 |
|
| 2004 |
Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Biochemical and Biophysical Research Communications. 316: 421-8. PMID 15020235 DOI: 10.1016/J.Bbrc.2004.02.062 |
0.316 |
|
| 2004 |
James AC, Veitch JG, Zareh AR, Triche T. Sensitivity and specificity of five abundance estimators for high-density oligonucleotide microarrays Bioinformatics. 20: 1060-1065. PMID 14764574 DOI: 10.1093/Bioinformatics/Bth038 |
0.316 |
|
| 2002 |
McManus BM, Yanagawa B, Rezai N, Luo H, Taylor L, Zhang M, Yuan J, Buckley J, Triche T, Schreiner G, Yang D. Genetic determinants of coxsackievirus B3 pathogenesis. Annals of the New York Academy of Sciences. 975: 169-79. PMID 12538163 DOI: 10.1111/J.1749-6632.2002.Tb05950.X |
0.326 |
|
| 2002 |
Wang J, Barsky LW, Shum CH, Jong A, Weinberg KI, Collins SJ, Triche TJ, Wu L. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. The Journal of Biological Chemistry. 277: 43369-76. PMID 12213824 DOI: 10.1074/jbc.M206792200 |
0.773 |
|
| 2002 |
Schofield D, Triche TJ. cDNA microarray analysis of global gene expression in sarcomas. Current Opinion in Oncology. 14: 406-11. PMID 12130925 DOI: 10.1097/00001622-200207000-00007 |
0.394 |
|
| 2002 |
Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2672-9. PMID 12039929 DOI: 10.1200/Jco.2002.03.137 |
0.329 |
|
| 2001 |
Ladanyi M, Chan WC, Triche TJ, Gerald WL. Expression profiling of human tumors: the end of surgical pathology? The Journal of Molecular Diagnostics : Jmd. 3: 92-7. PMID 11486047 DOI: 10.1016/S1525-1578(10)60657-5 |
0.401 |
|
| 2001 |
Wu L, Chen P, Shum CH, Chen C, Barsky LW, Weinberg KI, Jong A, Triche TJ. MAT1-modulated CAK activity regulates cell cycle G(1) exit. Molecular and Cellular Biology. 21: 260-70. PMID 11113200 DOI: 10.1128/Mcb.21.1.260-270.2001 |
0.773 |
|
| 2000 |
Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes, Chromosomes and Cancer. 27: 337-344. PMID 10719362 DOI: 10.1002/(Sici)1098-2264(200004)27:4<337::Aid-Gcc1>3.0.Co;2-1 |
0.31 |
|
| 1999 |
Kouraklis G, Triche TJ, Wesley R, Tsokos M. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines. Pediatric Research. 45: 552-8. PMID 10203148 DOI: 10.1203/00006450-199904010-00015 |
0.362 |
|
| 1999 |
Monforte-Muñoz H, Lopez-Terrada D, Affendie H, Rowland JM, Triche TJ. Documentation of EWS gene rearrangements by fluorescence in-situ hybridization (FISH) in frozen sections of Ewing's sarcoma-peripheral primitive neuroectodermal tumor. The American Journal of Surgical Pathology. 23: 309-15. PMID 10078922 DOI: 10.1097/00000478-199903000-00010 |
0.352 |
|
| 1999 |
Shum CH, Jackson G, Haynes JA, Liu XF, Triche TJ. Downstream targets of the Ewing's sarcoma EWS/FLI-1 fusion gene Journal of Investigative Medicine. 47: 82A. |
0.76 |
|
| 1998 |
Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM, Crist WM. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 1: 550-61. PMID 9724344 DOI: 10.1007/S100249900076 |
0.311 |
|
| 1996 |
Tomayko MM, Triche TJ, Reynolds CP. Human neuroblastoma cell lines regain catecholamine fluorescence when xenografted into athymic (nude) mice. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 14: 771-7. PMID 8960984 DOI: 10.1016/S0736-5748(96)00050-0 |
0.352 |
|
| 1996 |
Sorensen PH, Triche TJ. Gene fusions encoding chimaeric transcription factors in solid tumours. Seminars in Cancer Biology. 7: 3-14. PMID 8695764 DOI: 10.1006/Scbi.1996.0002 |
0.344 |
|
| 1996 |
Sorensen PH, Wu JK, Berean KW, Lim JF, Donn W, Frierson HF, Reynolds CP, López-Terrada D, Triche TJ. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 93: 1038-43. PMID 8577710 DOI: 10.1073/Pnas.93.3.1038 |
0.371 |
|
| 1996 |
Shum CH, Triche TJ. Expression of a human homolog of mouse neurogenic differentiation factor in pediatric soft-tissue sarcomas Journal of Investigative Medicine. 44: 165A. |
0.768 |
|
| 1995 |
Terrier P, Henry-Amar M, Triche TJ, Horowitz ME, Terrier-Lacombe MJ, Miser JS, Kinsella TJ, Contesso G, Llombart-Bosch A. Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis? European Journal of Cancer (Oxford, England : 1990). 31: 307-14. PMID 7786593 DOI: 10.1016/0959-8049(94)00417-4 |
0.31 |
|
| 1994 |
Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. The New England Journal of Medicine. 331: 294-9. PMID 8022439 DOI: 10.1056/Nejm199408043310503 |
0.376 |
|
| 1993 |
De Chiara A, T'Ang A, Triche TJ. Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas. Journal of the National Cancer Institute. 85: 152-7. PMID 8418305 DOI: 10.1093/Jnci/85.2.152 |
0.358 |
|
| 1993 |
Ota S, Crabbe DC, Tran TN, Triche TJ, Shimada H. Malignant rhabdoid tumor. A study with two established cell lines. Cancer. 71: 2862-72. PMID 8385567 DOI: 10.1002/1097-0142(19930501)71:9<2862::Aid-Cncr2820710930>3.0.Co;2-D |
0.363 |
|
| 1993 |
Navarro S, Pellín A, Noguera R, Díaz MP, Tsokos M, Triche TJ, Llombart-Bosch A. dbl oncogene expression in childhood tumors and tumor cell lines. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 2: 158-62. PMID 8287229 DOI: 10.1097/00019606-199300020-00025 |
0.388 |
|
| 1993 |
Sorensen PH, Liu XF, Delattre O, Rowland JM, Biggs CA, Thomas G, Triche TJ. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 2: 147-57. PMID 7506981 DOI: 10.1097/00019606-199300020-00024 |
0.371 |
|
| 1993 |
Boman Fh, Peters J, Ragge N, Triche T. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood. Diagnostic Molecular Pathology. 2: 14-22. DOI: 10.1097/00019606-199300020-00003 |
0.329 |
|
| 1991 |
Hartman KR, Triche TJ, Kinsella TJ, Miser JS. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors. Cancer. 67: 163-71. PMID 1985713 DOI: 10.1002/1097-0142(19910101)67:1<163::Aid-Cncr2820670128>3.0.Co;2-Y |
0.336 |
|
| 1990 |
Rettig WJ, Triche TJ, Bander NH. Somatic cell genetic analysis of human cell surface antigens 5.1H11 and F35/9 (gp45). Genomics. 6: 178-83. PMID 2303259 DOI: 10.1016/0888-7543(90)90464-6 |
0.314 |
|
| 1989 |
Bader JL, Horowitz ME, Dewan R, Watkins E, Triche TJ, Tsokos M, Kinsella TJ, Miser JS, Steinberg SM, Glatstein E. Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: local control and patterns of failure. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 16: 189-201. PMID 2587810 DOI: 10.1016/0167-8140(89)90019-4 |
0.329 |
|
| 1988 |
Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Forquer R, Wesley R, Horvath K, Belasco J, Longo DL, Steis R. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 484-90. PMID 3280743 DOI: 10.1200/Jco.1988.6.3.484 |
0.303 |
|
| 1987 |
Lieber MR, Lack EE, Roberts JR, Merino MJ, Patterson K, Restrepo C, Solomon D, Chandra R, Triche TJ. Solid and papillary epithelial neoplasm of the pancreas. An ultrastructural and immunocytochemical study of six cases American Journal of Surgical Pathology. 11: 85-93. PMID 3812876 DOI: 10.1097/00000478-198702000-00001 |
0.312 |
|
| 1987 |
Stea B, Kinsella TJ, Triche TJ, Horvath K, Glatstein E, Miser JS. Treatment of pelvic sarcomas in adolescents and young adults with intensive combined modality therapy International Journal of Radiation Oncology, Biology, Physics. 13: 1797-1805. PMID 3679916 DOI: 10.1016/0360-3016(87)90344-0 |
0.302 |
|
| 1987 |
Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Jarosinski P, Forquer R, Wesley R, Magrath I. Ifosfamide with mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults Journal of Clinical Oncology. 5: 1191-1198. PMID 3114435 DOI: 10.1200/Jco.1987.5.8.1191 |
0.309 |
|
| 1987 |
Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP, Israel MA. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system Journal of Clinical Investigation. 80: 804-811. PMID 2887586 DOI: 10.1172/Jci113137 |
0.362 |
|
| 1986 |
Linnoila RI, Tsokos M, Triche TJ, Marangos PJ, Chandra RS. Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor"). The American Journal of Surgical Pathology. 10: 124-33. PMID 3953935 DOI: 10.1097/00000478-198602000-00005 |
0.349 |
|
| 1986 |
Whang-Peng J, Triche TJ, Knutsen T, Miser J, Kao-Shan S, Tsai S, Israel MA. Cytogenetic characterization of selected small round cell tumors of childhood Cancer Genetics and Cytogenetics. 21: 185-208. PMID 3004699 DOI: 10.1016/0165-4608(86)90001-4 |
0.34 |
|
| 1985 |
Fink IJ, Kurtz DW, Cazenave L, Lieber MR, Miser JS, Chandra R, Triche TJ. Malignant thoracopulmonary small-cell ("Askin") tumor. Ajr. American Journal of Roentgenology. 145: 517-20. PMID 2992255 DOI: 10.2214/Ajr.145.3.517 |
0.335 |
|
| 1984 |
Chadarevian JPd, Vekemans M, Seemayer TA, Whang-Peng J, Triche TJ, Knutsen T, Miser J, Israel MA. Reciprocal translocation in small-cell sarcomas. The New England Journal of Medicine. 311: 1702-1703. PMID 6504114 DOI: 10.1056/Nejm198412273112618 |
0.304 |
|
| 1984 |
Ahlgren AD, Simrell CR, Triche TJ, Ozols R, Barsky SH. Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy Cancer. 54: 2015-2018. PMID 6478436 DOI: 10.1002/1097-0142(19841101)54:9<2015::Aid-Cncr2820540939>3.0.Co;2-B |
0.319 |
|
| 1984 |
Tsokos M, Linnoila RI, Chandra RS, Triche TJ. Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Human Pathology. 15: 575-84. PMID 6373565 DOI: 10.1016/S0046-8177(84)80012-X |
0.341 |
|
| 1984 |
Magrath I, Erikson J, Whang-Peng J, Sieverts H, Armstrong G, Benjamin D, Triche T, Alabaster O, Croce CM. Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma. Science (New York, N.Y.). 222: 1094-8. PMID 6316501 DOI: 10.1126/Science.6316501 |
0.318 |
|
| 1984 |
Green WR, Linnoila RI, Triche TJ. Neuroendocrine carcinoma of skin with simultaneous cytokeratin expression Ultrastructural Pathology. 6: 141-152. PMID 6205492 DOI: 10.3109/01913128409018568 |
0.338 |
|
| 1984 |
Benjamin D, Magrath IT, Triche TJ, Schroff RW, Jensen JP, Korsmeyer SJ. Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations Proceedings of the National Academy of Sciences of the United States of America. 81: 3547-3551. PMID 6203124 DOI: 10.1073/Pnas.81.11.3547 |
0.365 |
|
| 1983 |
Kinsella TJ, Triche TJ, Dickman PS, Costa J, Tepper JE, Glaubiger D. Extraskeletal Ewing's sarcoma: Results of combined modality treatment Journal of Clinical Oncology. 1: 489-495. PMID 6668512 DOI: 10.1016/0360-3016(81)90562-9 |
0.302 |
|
| 1983 |
Goffman TE, Mulvihill JJ, Carney DN, Triche TJ, Whang-Peng J. Fatal hypereosinophilia with chromosome 15q- in a patient with multiple primary and familial neoplasms Cancer Genetics and Cytogenetics. 8: 197-202. PMID 6297705 DOI: 10.1016/0165-4608(83)90135-8 |
0.315 |
|
| 1982 |
Tralka TS, Yee C, Triche TJ, Costa J, Dienes HP. Unusual intranuclear inclusions in malignant fibrous histiocytoma: Presence in primary tumor Ultrastructural Pathology. 3: 161-167. PMID 6285572 DOI: 10.3109/01913128209016640 |
0.337 |
|
| 1982 |
Levine AM, Scordilis SP, Triche T. Osteosarcoma cells in tissue culture. III. Actin filament distribution. Clinical Orthopaedics and Related Research. 240-250. DOI: 10.1097/00003086-198211000-00042 |
0.315 |
|
| 1980 |
Azar HA, Jaffe ES, Berard CW, Callihan TR, Braylan RR, Cossman J, Triche TJ. Diffuse large cell lymphomas (reticulum cell sarcomas, histiocytic lymphomas). Correlation of morphologic features with functional markers Cancer. 46: 1428-1441. PMID 6998555 DOI: 10.1002/1097-0142(19800915)46:6<1428::Aid-Cncr2820460624>3.0.Co;2-R |
0.301 |
|
| 1980 |
Reddick RL, Michelitch HJ, Levine AM, Triche TJ. Osteogenic sarcoma. A study of the ultrastructure Cancer. 45: 64-71. PMID 6927959 DOI: 10.1002/1097-0142(19800101)45:1<64::Aid-Cncr2820450112>3.0.Co;2-5 |
0.348 |
|
| 1978 |
Triche TJ, Ross WE. Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing's sarcoma. Cancer. 41: 1425-32. PMID 639002 DOI: 10.1002/1097-0142(197804)41:4<1425::Aid-Cncr2820410430>3.0.Co;2-9 |
0.333 |
|
| 1978 |
Braylan RC, Jaffe ES, Triche TJ, Nanba K, Fowlkes BJ, Metzger H, Frank MM, Dolan MS, Yee CL, Green I, Berard CW. Structural and functional properties of the "hairy" cells of leukemic reticuloendotheliosis. Cancer. 41: 210-27. PMID 626930 DOI: 10.1002/1097-0142(197801)41:1<210::Aid-Cncr2820410130>3.0.Co;2-Y |
0.31 |
|
| Show low-probability matches. |